2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model

BACKGROUND: Fluconazole is lifesaving for the treatment and prevention of cryptococcosis; however, optimal dosing is unknown. Initial fluconazole doses of 100 mg to 2000 mg/day have been used. Prevalence of fluconazole non-susceptible Cryptococcus is increasing over time, risking the efficacy of lon...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Chesdachai, Supavit, Rajasingham, Radha, Nicol, Melanie R, Meya, David, Bongomin, Felix, Abassi, Mahsa, Skipper, Caleb, Kwizera, Richard, Rhein, Joshua, Boulware, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809647/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1800
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi